Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2856
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Clark, J. E. | en |
dc.contributor.author | Kapoor, V. | en |
dc.contributor.author | Heney, C. | en |
dc.contributor.author | Jones, C. A. | en |
dc.contributor.author | Nourse, C. | en |
dc.contributor.author | Lai, M. M. | en |
dc.contributor.author | Vaska, V. L. | en |
dc.contributor.author | Britton, P. N. | en |
dc.contributor.author | Berkhout, A. | en |
dc.date.accessioned | 2022-11-07T23:35:57Z | - |
dc.date.available | 2022-11-07T23:35:57Z | - |
dc.date.issued | 2022 | en |
dc.identifier.citation | , 2022 | en |
dc.identifier.other | RIS | en |
dc.identifier.uri | http://dora.health.qld.gov.au/qldresearchjspui/handle/1/2856 | - |
dc.description.abstract | Aim: Herpes simplex CNS infection is a rare but important cause of neurological disability. Long term outcomes after HSV CNS infection in Australia have not yet been fully described. We sought to provide a comprehensive review of HSV CNS infection in children using a retrospective 13-year evaluation of statewide laboratory and clinical records and a parent survey conducted at least one year after the initial infection. Methods: All positive PCR HSV 1 and 2 results from cerebrospinal fluid (CSF) or brain tissue were obtained from Queensland pathology providers for children aged 0–16 years between 1 January 2005 and 31 December 2017. Clinical data were obtained from patient records and longer-term outcomes via parent survey at least 1 year after initial infection. Results: Forty-three children were identified over the 13-year period, 17 (39.5%) neonates and 26 (60.4%) non-neonates. The annual incidence for HSV CNS infection in Queensland children aged ≤16 years was 0.3/100 000 (95% confidence intervals (CIs): 0.2–0.4) with neonates at highest risk (incidence 2.5/100 000 live births, 95% CI: 1.5–3.9). HSV 1 was the predominant serotype in both neonates and non-neonates (9/17, 52.9% neonates and 19/26, 73.1% non-neonates). Seven (16.3%) children died, five (5/17, 29.4% neonates), directly attributable to HSV CNS infection (all neonates). Twenty-five (58.1%) had neurological morbidity at discharge (9/17 neonates (52.9%) vs. 16/26 (61.5%) non-neonates) and 20/27 (74.1%) reported long-term neurological morbidity at follow-up (5/9 neonates (55.6%) vs. 15/18 non-neonates (83.3%)). Seven children (two neonates and four non-neonates) with long-term neurological sequelae had no neurological morbidity identified at discharge. Conclusion: Significant long-term neurologic sequelae were seen in children with HSV CNS infection even in children with no neurological disability identified at discharge from hospital. Careful neurodevelopmental follow-up of all children is recommended.L20163889022022-05-10 <br /> | en |
dc.language.iso | en | en |
dc.relation.ispartof | Journal of Paediatrics and Child Health | en |
dc.title | Epidemiology and long-term neurological sequelae of childhood herpes simplex CNS infection | en |
dc.type | Article | en |
dc.identifier.doi | 10.1111/jpc.15992 | en |
dc.subject.keywords | central nervous system infection | en |
dc.subject.keywords | cerebrospinal fluid | en |
dc.subject.keywords | child | en |
dc.subject.keywords | childhood | en |
dc.subject.keywords | clinical article | en |
dc.subject.keywords | complication | en |
dc.subject.keywords | encephalitis | en |
dc.subject.keywords | female | en |
dc.subject.keywords | follow up | en |
dc.subject.keywords | herpes simplex | en |
dc.subject.keywords | Herpes simplex virus | en |
dc.subject.keywords | human | en |
dc.subject.keywords | Human alphaherpesvirus 1 | en |
dc.subject.keywords | incidence | en |
dc.subject.keywords | brain tissue | en |
dc.subject.keywords | male | en |
dc.subject.keywords | medical record | en |
dc.subject.keywords | morbidity | en |
dc.subject.keywords | neurodisability | en |
dc.subject.keywords | neurological complication | en |
dc.subject.keywords | newborn | en |
dc.subject.keywords | nonhuman | en |
dc.subject.keywords | outcome assessment | en |
dc.subject.keywords | Queensland | en |
dc.subject.keywords | serotype | en |
dc.subject.keywords | Australia | en |
dc.subject.keywords | adolescentarticle | en |
dc.subject.keywords | live birth | en |
dc.subject.keywords | case report | en |
dc.subject.keywords | central nervous system | en |
dc.relation.url | https://www.embase.com/search/results?subaction=viewrecord&id=L2016388902&from=exporthttp://dx.doi.org/10.1111/jpc.15992 | | en |
dc.identifier.risid | 2071 | en |
local.message.claim | 2024-06-20T09:21:31.234+1000|||rp03979|||submit_approve|||dc_contributor_author|||None | * |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
Appears in Sites: | Children's Health Queensland Publications Queensland Health Publications |
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.